Showing results (1-10 of 135) with videos related to
Sort By:
Pageof 14
Molecular Psychiatry|December 9, 2021
Pyroglutamate Aβ cascade as drug target in Alzheimer's diseaseThomas A BayerFrontiers in Aging Neuroscience|September 7, 2021
N-Truncated Aβ Starting at Position Four-Biochemical Features, Preclinical Models, and Potential as Drug Target in Alzheimer's DiseaseThomas A BayerEuropean Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 7, 2013
Proteinopathies, a core concept for understanding and ultimately treating degenerative disorders?Thomas A BayerInternational Journal of Alzheimer'S Disease|September 28, 2010
Neuron loss in transgenic mouse models of Alzheimer's diseaseOliver Wirths, Thomas A BayerJournal of Alzheimer'S Disease : JAD|November 26, 2005
Involvement of amyloid beta precursor protein (AbetaPP) modulated copper homeostasis in Alzheimer's diseaseThomas A Bayer, Gerd MulthaupActa Neuropathologica|May 8, 2014
Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer's diseaseThomas A Bayer, Oliver WirthsProgress in Neuro-Psychopharmacology & Biological Psychiatry|January 29, 2003
Alpha-synuclein, Abeta and Alzheimer's diseaseOliver Wirths, Thomas A BayerFrontiers in Aging Neuroscience|June 17, 2010
Intracellular accumulation of amyloid-Beta - a predictor for synaptic dysfunction and neuron loss in Alzheimer's diseaseThomas A Bayer, Oliver WirthsLife Sciences|March 10, 2012
Intraneuronal Aβ accumulation and neurodegeneration: lessons from transgenic modelsOliver Wirths, Thomas A BayerBiochemical Society Transactions|July 27, 2011
Intraneuronal Aβ as a trigger for neuron loss: can this be translated into human pathology?Thomas A Bayer, Oliver WirthsPageof 14